Worldwide Dry Eye Syndrome Industry to 2027 - Featuring Akorn, Allergan and Nicox Among Others
March 03, 2022 07:53 ET
|
Research and Markets
Dublin, March 03, 2022 (GLOBE NEWSWIRE) -- The "Dry Eye Syndrome Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
AXIM Biotech Announces New Milestones in Preparation of Dry Eye Disease Diagnostics Launch
February 15, 2022 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
AXIM is driven to positively transform the state of Dry Eye Disease (DED) testing and diagnosis The company will deploy industry leader IUL’s state-of-the-art iPeak readers Company Adds Veteran Lab...
Sohi Eye Care Announces Grand Opening of hEYEdrate Spa in Raleigh, NC
February 10, 2022 14:02 ET
|
Sohi Eye Care
RALEIGH, N.C., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Whether the condition is acute or chronic, dry eye syndrome can negatively impact a person's eye health and overall quality of life. That's why the...
I-Med Pharma USA Partners With DryEye Rescue to Distribute Its Innovative Dry Eye Product Portfolio in the United States
February 03, 2022 11:00 ET
|
I-MED Pharma
MONTREAL, Feb. 03, 2022 (GLOBE NEWSWIRE) -- With the recent launch of its line of dry eye diagnostics, management, and treatment solutions into the United States, I-MED Pharma USA has partnered with...
CDC Publishes AXIM® Biotechnologies-Sponsored Study on COVID-19 Neutralizing Antibodies
December 21, 2021 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, Dec. 21, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting COVID-19...
Insights on the Pharma Ophthalmic Global Market to 2026 - Featuring Roche, Santen and Senju Among Others
December 16, 2021 09:48 ET
|
Research and Markets
Dublin, Dec. 16, 2021 (GLOBE NEWSWIRE) -- The "Pharma Ophthalmic Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type" report...
NTC and I-MED Pharma form strategic partnership to bring the leading HA-based dry eye ointment to the United States market
December 15, 2021 07:00 ET
|
I-MED Pharma
MONTREAL, Dec. 15, 2021 (GLOBE NEWSWIRE) -- NTC Srl, R&D driven pharmaceutical company with headquarters in Italy, and I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and...
I-MED Pharma USA Announces Michelle Schnabel as VP Business Development
November 09, 2021 11:00 ET
|
I-MED Pharma
MONTREAL, Nov. 09, 2021 (GLOBE NEWSWIRE) -- With the recent expansion into the United States, I-MED Pharma USA is proud to announce the appointment of Michelle Schnabel to the role of VP Business...
I-MED Pharma USA Announces Brent Jones as Chief Commercial Officer
November 08, 2021 11:00 ET
|
I-MED Pharma
MONTREAL, Nov. 08, 2021 (GLOBE NEWSWIRE) -- With the recent expansion into the United States, I-MED Pharma USA is proud to announce the appointment of Brent Jones to Chief Commercial Officer...
I-MED Pharma Set to Launch Its Innovative Dry Eye Product Portfolio in the U.S.A.
November 05, 2021 11:00 ET
|
I-MED Pharma
MONTREAL, Nov. 05, 2021 (GLOBE NEWSWIRE) -- I-MED Pharma USA is bringing the world’s most innovative dry eye product portfolio to the U.S. market. Their uniquely formulated line of ocular surface...